Profile data is unavailable for this security.
About the company
Alphatec Holdings, Inc., through its wholly owned subsidiaries, Alphatec Spine, Inc., EOS imaging S.A.S. and SafeOp Surgical, Inc., is a medical device company. The Company is focused on the design, development, and advancement of technology for surgical treatment of spine disorders. It has a range of product portfolios designed to address the spine's various pathologies. Its AIX product platform comprises of its EOS imaging system and VEA alignment mobile application, its SafeOp Neural InformatiX System and Valence. The EOS imaging system is designed to provide calibrated full-body imaging that enables a three-dimensional (3D) model of patients’ skeletal systems. It has developed a patient positioning systems that integrates with its other access systems, providing for a more rigid construct and enhanced reproducibility. It offers procedure-specific access systems, including its Sigma-ALIF Access System, which allows for custom anterior abdominal exposure.
- Revenue in USD (TTM)511.63m
- Net income in USD-191.60m
- Incorporated2005
- Employees839.00
- LocationAlphatec Holdings Inc5818 El Camino RealCARLSBAD 92008United StatesUSA
- Phone+1 (760) 431-9286
- Fax+1 (302) 636-5454
- Websitehttps://atecspine.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Artivion Inc | 368.21m | -9.58m | 978.26m | 1.50k | -- | 3.32 | 71.79 | 2.66 | -0.2615 | -0.2615 | 8.64 | 7.07 | 0.4779 | 1.64 | 5.37 | 245,470.70 | -1.25 | -2.20 | -1.33 | -2.36 | 64.75 | 65.51 | -2.61 | -5.34 | 4.26 | 2.26 | 0.5176 | -- | 12.82 | 6.14 | -60.09 | -- | 5.13 | -- |
| BioLife Solutions Inc | 137.30m | -62.93m | 1.03bn | 409.00 | -- | 3.07 | -- | 7.52 | -1.43 | -1.43 | 3.10 | 7.30 | 0.3238 | 2.17 | 5.61 | 335,687.00 | -14.84 | -13.76 | -16.52 | -15.04 | 32.97 | 36.76 | -45.84 | -42.99 | 1.77 | -32.08 | 0.0717 | -- | -11.43 | 48.65 | 52.49 | -- | 86.35 | -- |
| Perspective Therapeutics Inc | 1.43m | -37.46m | 1.03bn | 116.00 | -- | 6.60 | -- | 720.69 | -0.1399 | -0.1738 | 0.0054 | 0.2668 | 0.0184 | -- | 0.3321 | 12,362.07 | -48.02 | -- | -54.42 | -- | 102.72 | -- | -2,611.93 | -- | -- | -- | 0.0224 | -- | -- | -- | -- | -- | -- | -- |
| AtriCure Inc | 414.60m | -37.23m | 1.06bn | 1.20k | -- | 2.32 | -- | 2.55 | -0.8005 | -0.8005 | 8.92 | 9.43 | 0.7059 | 1.70 | 8.21 | 345,501.70 | -6.34 | -3.72 | -7.08 | -4.10 | 75.26 | 74.36 | -8.98 | -7.64 | 2.83 | -10.27 | 0.1212 | -- | 20.84 | 14.64 | 34.49 | -- | 46.56 | -- |
| Coretag Inc | 0.00 | -39.35k | 1.13bn | -- | -- | -- | -- | -- | -0.4372 | -0.4372 | 0.00 | -0.93 | 0.00 | -- | -- | -- | -78,700.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 10.95 | -- | -- | -- |
| MiMedx Group Inc | 334.51m | 71.52m | 1.16bn | 895.00 | 20.92 | 7.46 | 14.60 | 3.48 | 0.3767 | 0.3393 | 2.15 | 1.06 | 1.72 | 2.82 | 6.58 | 373,754.20 | 41.80 | -4.14 | 53.13 | -5.90 | 83.50 | 83.61 | 24.36 | -2.70 | 2.71 | 9.00 | 0.111 | -- | 20.03 | -2.19 | 310.29 | -- | -26.47 | -- |
| Adapthealth Corp | 3.25bn | -695.41m | 1.31bn | 10.70k | -- | 0.8957 | -- | 0.4031 | -5.18 | -5.18 | 24.27 | 10.97 | 0.6637 | 21.66 | 8.30 | 303,555.90 | -14.15 | -4.34 | -15.82 | -4.89 | 18.45 | 18.28 | -21.32 | -6.47 | 1.11 | 41.09 | 0.6025 | -- | 7.73 | -- | -1,169.99 | -- | -- | -- |
| Owens & Minor, Inc. | 10.42bn | -38.77m | 1.51bn | 13.70k | -- | 1.69 | 6.01 | 0.1452 | -0.5099 | -0.5099 | 136.98 | 11.71 | 1.98 | 6.79 | 14.60 | 760,861.20 | -0.7372 | 1.32 | -1.11 | 2.07 | 20.75 | 16.48 | -0.3719 | 0.5614 | 0.5648 | 2.19 | 0.7065 | 0.798 | 3.80 | 1.87 | -284.47 | -- | 25.91 | -- |
| Alphatec Holdings Inc | 511.63m | -191.60m | 1.52bn | 839.00 | -- | 41.22 | -- | 2.97 | -1.49 | -1.49 | 3.97 | 0.4294 | 0.7612 | 1.34 | 6.70 | 609,808.10 | -28.51 | -30.97 | -37.13 | -39.47 | 65.89 | 66.02 | -37.45 | -46.22 | 1.49 | -5.17 | 0.8938 | -- | 37.45 | 39.38 | -23.36 | -- | 67.92 | -- |
| Inmode Ltd | 466.26m | 181.11m | 1.57bn | 581.00 | 8.82 | 1.88 | 8.65 | 3.37 | 2.11 | 2.11 | 5.42 | 9.87 | 0.5973 | 1.71 | 16.09 | 802,509.40 | 23.20 | 31.32 | 25.21 | 35.64 | 83.10 | 84.46 | 38.84 | 39.65 | 12.66 | -- | 0.00 | 0.00 | 8.32 | 37.49 | 22.54 | 54.65 | 13.10 | -- |
| Establishment Labs Holdings Inc | 155.79m | -82.76m | 1.61bn | 781.00 | -- | 28.39 | -- | 10.37 | -3.15 | -3.15 | 5.91 | 2.07 | 0.6095 | 0.9191 | 3.39 | 171,579.30 | -32.38 | -33.22 | -39.25 | -41.12 | 65.01 | 64.73 | -53.12 | -43.19 | 2.73 | -21.30 | 0.7715 | -- | 2.13 | 21.96 | -4.38 | -- | 69.16 | -- |
| LeMaitre Vascular Inc | 199.89m | 33.95m | 1.75bn | 614.00 | 51.70 | 5.68 | 40.27 | 8.76 | 1.51 | 1.51 | 8.89 | 13.74 | 0.5977 | 1.17 | 7.19 | 325,548.90 | 10.15 | 9.02 | 10.99 | 9.93 | 66.45 | 65.83 | 16.99 | 15.45 | 5.31 | -- | 0.00 | 40.41 | 19.69 | 12.88 | 45.89 | 5.96 | 18.93 | 15.51 |
| Warby Parker Inc | 697.80m | -55.06m | 1.85bn | 2.14k | -- | 5.85 | -- | 2.65 | -0.467 | -0.467 | 5.91 | 2.66 | 1.21 | 5.19 | 655.52 | 326,074.80 | -9.57 | -- | -11.95 | -- | 55.01 | 57.49 | -7.89 | -14.53 | 2.02 | -- | 0.00 | -- | 11.98 | 19.67 | 42.75 | -- | -- | -- |
| UFP Technologies Inc | 407.33m | 47.88m | 2.01bn | 3.09k | 42.31 | 6.83 | 33.86 | 4.95 | 6.21 | 6.21 | 52.82 | 38.46 | 1.02 | 4.50 | 6.71 | 131,693.20 | 11.99 | 9.69 | 13.80 | 10.95 | 27.89 | 26.33 | 11.75 | 10.14 | 1.46 | 17.87 | 0.1039 | 0.00 | 13.08 | 16.00 | 7.50 | 25.71 | 14.08 | -- |
| Premier Inc | 1.34bn | 80.33m | 2.07bn | 2.80k | 30.74 | 1.08 | 10.51 | 1.55 | 0.6421 | 0.6421 | 11.34 | 18.35 | 0.3887 | 5.25 | 3.10 | 477,306.10 | 1.89 | 10.39 | 2.48 | 13.00 | 66.20 | 62.04 | 4.87 | 22.60 | 0.8226 | 143.62 | 0.276 | 19.11 | -6.76 | 2.44 | -34.17 | -15.30 | -2.29 | -- |
Data as of May 15 2024. Currency figures normalised to Alphatec Holdings Inc's reporting currency: US Dollar USD
27.53%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| BlackRock Fund Advisorsas of 31 Mar 2024 | 6.76m | 4.90% |
| First Light Asset Management LLCas of 31 Dec 2023 | 5.98m | 4.33% |
| The Vanguard Group, Inc.as of 31 Mar 2024 | 5.27m | 3.82% |
| American Century Investment Management, Inc.as of 31 Dec 2023 | 3.56m | 2.58% |
| Alyeska Investment Group LPas of 31 Dec 2023 | 3.12m | 2.26% |
| Point72 Asset Management LPas of 31 Dec 2023 | 3.00m | 2.17% |
| JPMorgan Investment Management, Inc.as of 31 Mar 2024 | 2.77m | 2.01% |
| Driehaus Capital Management LLCas of 31 Dec 2023 | 2.61m | 1.89% |
| Millennium Management LLCas of 31 Dec 2023 | 2.52m | 1.83% |
| SSgA Funds Management, Inc.as of 31 Dec 2023 | 2.40m | 1.74% |
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
